Which drug will the nurse plan to include when teaching a patient who has a new diagnosis of peripheral artery disease (PAD)?

Rationale: A. Doxycycline: Doxycycline is an antibiotic used to treat bacterial infections. It has no role in the management or prevention of peripheral artery disease and does not affect atherosclerotic plaque or vascular health. B. Apixaban: Apixaban is an anticoagulant used to prevent thromboembolic events in conditions such as atrial fibrillation or venous thromboembolism. While it affects clotting, it is not a standard therapy for managing the underlying atherosclerosis in peripheral artery disease. C. Atorvastatin: Atorvastatin is a statin that lowers LDL cholesterol and stabilizes atherosclerotic plaques. It reduces the risk of cardiovascular events and is a cornerstone in the pharmacologic management of peripheral artery disease, helping improve long-term vascular outcomes. D. Enoxaparin: Enoxaparin is a low molecular weight heparin used for acute anticoagulation and prevention of deep vein thrombosis. It is not routinely indicated for chronic management of peripheral artery disease unless there is a specific thrombotic complication.